BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaw R, Gota C, Bennett A, Barnes D, Calabrese L. Lupus-related hepatitis: complication of lupus or autoimmune association? Case report and review of the literature. Dig Dis Sci. 2006;51:813-818. [PMID: 16615009 DOI: 10.1007/s10620-006-3212-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Schlenker C, Halterman T, Kowdley KV. Rheumatologic disease and the liver. Clin Liver Dis 2011;15:153-64. [PMID: 21111998 DOI: 10.1016/j.cld.2010.09.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
2 Lai WT, Cho WH, Eng HL, Kuo MH, Huang FC. Overlap Syndrome Involving Systemic Lupus Erythematosus and Autoimmune Hepatitis in Children: A Case Report and Literature Review. Front Pediatr 2019;7:310. [PMID: 31428592 DOI: 10.3389/fped.2019.00310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Grover S, Rastogi A, Singh J, Rajbongshi A, Bihari C. Spectrum of Histomorphologic Findings in Liver in Patients with SLE: A Review. Hepat Res Treat 2014;2014:562979. [PMID: 25136456 DOI: 10.1155/2014/562979] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
4 Pawłowska J, Naorniakowska M, Liber A. Liver involvement in children with collagen vascular diseases. Clin Exp Hepatol 2015;1:117-9. [PMID: 28856258 DOI: 10.5114/ceh.2015.55569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Sarda G, Harvey R. Severe transaminitis in a paediatric patient with systemic lupus erythaematosus and a discussion of the literature. BMJ Case Rep 2016;2016:10.1136/bcr-2015-214159. [PMID: 27090540 DOI: 10.1136/bcr-2015-214159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Barkhudarova F, Dähnrich C, Rosemann A, Schneider U, Stöcker W, Burmester GR, Egerer K, Schlumberger W, Hiepe F, Biesen R. Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus. Arthritis Res Ther 2011;13:R20. [PMID: 21310064 DOI: 10.1186/ar3244] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
7 Usta Y, Gurakan F, Akcoren Z, Ozen S. An overlap syndrome involving autoimmune hepatitis and systemic lupus erythematosus in childhood. World J Gastroenterol 2007; 13(19): 2764-2767 [PMID: 17569152 DOI: 10.3748/wjg.v13.i19.2764] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
8 Choi MY, FitzPatrick RD, Buhler K, Mahler M, Fritzler MJ. A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus. Autoimmun Rev 2020;19:102463. [PMID: 31927088 DOI: 10.1016/j.autrev.2020.102463] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
9 Beisel C, Weiler-Normann C, Teufel A, Lohse AW. Association of autoimmune hepatitis and systemic lupus erythematodes: A case series and review of the literature. World J Gastroenterol 2014; 20(35): 12662-12667 [PMID: 25253972 DOI: 10.3748/wjg.v20.i35.12662] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
10 Vital Durand D, Lega J, Fassier T, Zenone T, Durieu I. Élévation modérée, persistante et inexpliquée des transaminases. La Revue de Médecine Interne 2013;34:472-8. [DOI: 10.1016/j.revmed.2013.02.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Calich AL, Viana VS, Cancado E, Tustumi F, Terrabuio DR, Leon EP, Silva CA, Borba EF, Bonfa E. Anti-ribosomal P protein: a novel antibody in autoimmune hepatitis. Liver Int. 2013;33:909-913. [PMID: 23522300 DOI: 10.1111/liv.12155] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
12 Jearn L, Kim T. The antiribosomal P antibodies really elicit autoimmune hepatitis? Liver Int 2014;34:165-6. [DOI: 10.1111/liv.12333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Adiga A, Nugent K. Lupus Hepatitis and Autoimmune Hepatitis (Lupoid Hepatitis). The American Journal of the Medical Sciences 2017;353:329-35. [DOI: 10.1016/j.amjms.2016.10.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
14 . Bibliography. Current world literature. Myositis and myopathies. Curr Opin Rheumatol 2007;19:651-3. [PMID: 17917548 DOI: 10.1097/BOR.0b013e3282f20347] [Reference Citation Analysis]
15 Teufel A, Weinmann A, Kahaly GJ, Centner C, Piendl A, Wörns M, Lohse AW, Galle PR, Kanzler S. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol. 2010;44:208-213. [PMID: 20087196 DOI: 10.1097/mcg.0b013e3181c74e0d] [Cited by in Crossref: 123] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
16 Ahmad A, Heijke R, Eriksson P, Wirestam L, Kechagias S, Dahle C, Sjöwall C. Autoantibodies associated with primary biliary cholangitis are common among patients with systemic lupus erythematosus even in the absence of elevated liver enzymes. Clin Exp Immunol 2021;203:22-31. [PMID: 32910463 DOI: 10.1111/cei.13512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ohira H, Abe K, Takahashi A. Involvement of the liver in rheumatic diseases. Clin J Gastroenterol 2012;5:9-14. [DOI: 10.1007/s12328-011-0271-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Muratori P, Lenzi M, Cassani F, Lalanne C, Muratori L. Diagnostic approach to autoimmune hepatitis. Expert Rev Clin Immunol 2017;13:769-79. [PMID: 28480763 DOI: 10.1080/1744666X.2017.1327355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]